Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2023-10-31 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Board Meeting — ADVANCED ENZYME TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the…
Regulatory Filings
2023-10-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the scheduling of a Board Meeting to consider and approve unaudited financial results for the quarter and half year ended September 30, 2023. It also mentions the closure of the trading window. The document does not contain any financial data or detailed results itself, but is an announcement of an upcoming event and related procedural information. The length is only 1492 characters, which is quite short and fits the pattern of an announcement rather than a full report. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as a general announcement to the stock exchanges and public about the Board Meeting and trading window closure.
2023-10-31 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, related to the quarter ended September 30, 2023. It is a short communication certifying compliance with a regulatory requirement, not a financial report or detailed filing. The document length is only 1015 characters, indicating it is a brief certificate rather than a full report. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory compliance certificates and miscellaneous filings.
2023-10-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window in compliance with insider trading regulations ahead of the company's upcoming financial results announcement. It does not contain any financial data, results, or detailed report content. The document is an announcement related to regulatory compliance and trading restrictions, not a financial report or earnings release itself. Given the short length (1173 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed presentation, or report content. The document length is only 1280 characters, indicating it is a brief announcement rather than a full report or transcript. It does not provide financial results or detailed analysis, nor does it include voting results or management changes. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2023-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled Analyst / Institutional Investor Meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the meeting date and type. There is no financial data, report content, or detailed presentation included. The document is an announcement of an upcoming investor meeting rather than the meeting materials or transcript itself. Given the short length (1491 characters) and nature of the content, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-09-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.